Thank you to our speakers, sponsors, and delegates who joined us for the summit! If you are interested in the 2023 event, please get in touch at info@hansonwade.com

ild image

Trouble downloading the brochure?
Request a copy here

Your Top 5 Takeaways From Key Stakeholders:

  • Uncover the clinical research propelling ILD drug development forwards in 2022 with Boehringer Ingelheim and Novartis to further
  • Investigate emerging ILD therapeutic approaches with Saje Pharma and Pieris Pharmaceuticals
  • Discover how pneumoproteitns and cytokines can be used to strategically enrich SSc-ILD clinical trials with The University of Texas
  • Examine inflammatory interstitial lung disease from a drug development perspective with Pfizer
  • Deep dive into the lumping versus splitting debate in the context of disease progression with McMaster University